MedTrace Logo

Intelligent Control Approach to Anemia Management

NCT00572533 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2017-12-13

Study results available
· View outcomes & findings →

Summary

First clinical evaluation of "Smart Anemia Manager" algorithm.

Conditions

  • End-Stage Renal Disease

Interventions

OTHER

ESA Dose Adjustment per standard Anemia Management Protocol

Amount of ESA dose adjustment in Units per week guided by standard Anemia Management Protocol in use at the facility

OTHER

ESA Dose Adjustment per "Smart Anemia Manager" Algorithm

Amount of ESA dose adjustment in Units per week individualized to subject's dose-response profile guided by "Smart Anemia Manager" algorithm

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • University of Louisville

    lead OTHER

Principal Investigators

  • Adam E Gaweda, Ph.D. · University of Louisville

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2012-04-30
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00572533 on ClinicalTrials.gov